News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
782,099 Results
Type
Article (63942)
Company Profile (641)
Press Release (717516)
Section
Business (222656)
Career Advice (3171)
Deals (38226)
Drug Delivery (124)
Drug Development (87861)
Employer Resources (186)
FDA (17609)
Job Trends (16456)
News (378418)
Policy (37352)
Tag
Academia (2972)
Alliances (55059)
Alzheimer's disease (1432)
Approvals (17564)
Artificial intelligence (243)
Bankruptcy (389)
Best Places to Work (12531)
Biotechnology (438)
Breast cancer (248)
Cancer (1896)
Cardiovascular disease (152)
Career advice (2667)
CAR-T (146)
Cell therapy (406)
Clinical research (70346)
Collaboration (751)
Compensation (380)
COVID-19 (2839)
C-suite (185)
Data (1731)
Diabetes (244)
Diagnostics (6805)
Earnings (91011)
Employer resources (161)
Events (122265)
Executive appointments (620)
FDA (18599)
Funding (661)
Gene therapy (287)
GLP-1 (776)
Government (4963)
Healthcare (20699)
Infectious disease (2970)
Inflammatory bowel disease (139)
Interviews (583)
IPO (17402)
Job creations (4430)
Job search strategy (2222)
Layoffs (508)
Legal (9282)
Lung cancer (280)
Manufacturing (271)
Medical device (14420)
Medtech (14425)
Mergers & acquisitions (21208)
Metabolic disorders (653)
Neuroscience (1902)
NextGen: Class of 2025 (7504)
Non-profit (5058)
Northern California (2230)
Obesity (362)
Opinion (260)
Patents (187)
People (62192)
Phase I (21833)
Phase II (30767)
Phase III (23135)
Pipeline (814)
Postmarket research (3010)
Preclinical (9585)
Radiopharmaceuticals (263)
Rare diseases (370)
Real estate (6852)
Regulatory (25062)
Research institute (2636)
Resumes & cover letters (502)
Southern California (1927)
Startups (4044)
United States (20398)
Vaccines (726)
Weight loss (270)
Date
Today (90)
Last 7 days (803)
Last 30 days (2839)
Last 365 days (36659)
2025 (5670)
2024 (37661)
2023 (42400)
2022 (53746)
2021 (58498)
2020 (57431)
2019 (50977)
2018 (38762)
2017 (35760)
2016 (36017)
2015 (42009)
2014 (36186)
2013 (32036)
2012 (34333)
2011 (34577)
2010 (32901)
Location
Africa (1010)
Arizona (243)
Asia (45117)
Australia (7731)
California (5211)
Canada (1784)
China (436)
Colorado (238)
Connecticut (253)
Europe (101882)
Florida (746)
Georgia (183)
Illinois (530)
Indiana (291)
Maryland (817)
Massachusetts (4057)
Michigan (222)
Minnesota (368)
New Jersey (1463)
New York (1471)
North Carolina (1001)
Northern California (2230)
Ohio (187)
Pennsylvania (1161)
South America (1409)
Southern California (1927)
Texas (769)
Utah (162)
Washington State (517)
782,099 Results for "pro dex inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pro-Dex, Inc. Announces Fiscal 2024 Fourth Quarter and Full-Year Results
September 6, 2024
·
9 min read
Business
Pro-Dex, Inc. Announces Fiscal 2024 First Quarter Results
PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2024 first quarter ended September 30, 2023.
November 2, 2023
·
6 min read
Business
Pro-Dex, Inc. Announces Fiscal 2023 Third Quarter and Nine-Month Results
PRO-DEX, INC. announced financial results for its fiscal 2023 third quarter ended March 31, 2023.
May 4, 2023
·
8 min read
Business
Pro-Dex, Inc. Announces Fiscal 2023 Second Quarter and Six-Month Results
PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2023 second quarter ended December 31, 2022.
February 2, 2023
·
6 min read
Policy
Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform
Co-Diagnostics, Inc. announced that the Company has completed its first U.S. Food and Drug Administration application for 510 clearance for the Co-Dx™ PCR Pro™ instrument, and the Co-Dx PCR COVID-19 Test for over-the-counter use.
June 14, 2024
·
4 min read
Government
FTC Doubles Down on Tighter Merger Rules Despite Trump’s Pro-Industry Posture
Despite expectations of dealmaking leniency, new FTC chairman Andrew Ferguson told staff that he will retain the current 2023 FTC and DOJ guidelines on mergers, upholding stricter anti-trust scrutiny on deals.
February 20, 2025
·
2 min read
·
Tristan Manalac
Deals
Simulations Plus Acquires Pro-ficiency, Creating One-of-a-Kind Platform Spanning the Drug Development Continuum
Simulations Plus, Inc. announced the acquisition of Pro-ficiency Holdings, Inc. and its subsidiaries, a leader in providing simulation-enabled performance and intelligence solutions for clinical and commercial drug development.
June 12, 2024
·
8 min read
Press Releases
Neurocrine Biosciences Reports Patient-Reported Outcome Data from KINECT-PRO™ Study for INGREZZA® (valbenazine) Capsules in Tardive Dyskinesia: Significant and Clinically Meaningful Improvements in Functionality and Quality of Life Measures
February 28, 2025
·
13 min read
Press Releases
Alcon Announces U.S. Launch of New SYSTANE PRO Preservative-Free, Revolutionizing Dry Eye Relief With Its Longest Lasting Formula Yet
February 24, 2025
·
3 min read
Press Releases
Quantum-Si Launches Platinum® Pro: The End-to-End Solution for Deeper Insights in Proteomics
January 13, 2025
·
5 min read
1 of 78,210
Next
